Back to Search Start Over

Mucormycosis in COVID-19

Authors :
Vasantha Kamath
Manimegalai Mathivanan
R B Vinay
B Nivea
Source :
APIK Journal of Internal Medicine, Vol 9, Iss 4, Pp 209-214 (2021)
Publication Year :
2021
Publisher :
Wolters Kluwer Medknow Publications, 2021.

Abstract

Mucormycosis has emerged as a disease of immense importance, especially owing to the surge of cases during the second wave of COVID pandemic. Various factors are being attributed to the sudden burst of cases in our country, such as higher fungal spore counts in tropical climate, uncontrolled diabetes mellitus, prolonged steroid therapy, contamination of oxygen facilities, respiratory equipment, reused face mask, and zinc supplements. The need of the hour is to emphasize on awareness of early warning signs, as the benefits appear to be time sensitive.

Details

Language :
English
ISSN :
26661802 and 26661810
Volume :
9
Issue :
4
Database :
Directory of Open Access Journals
Journal :
APIK Journal of Internal Medicine
Publication Type :
Academic Journal
Accession number :
edsdoj.2029bff073dc455f94934112698fe3d4
Document Type :
article
Full Text :
https://doi.org/10.4103/ajim.ajim_74_21